Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib.

Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib.

Item
http://www.wikidata.org/entity/Q38971845
Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cellsTAK-228 (formerly MLN0128), an investigational oral dual TORC1/2 inhibitor: A phase I dose escalation study in patients with relapsed or refractory multiple myeloma, non-Hodgkin lymphoma, or Waldenström's macroglobulinemia.Transgenic mouse model of IgM+ lymphoproliferative disease mimicking Waldenström macroglobulinemia.Kinase inhibitors as potential agents in the treatment of multiple myeloma.RNA interference for multiple myeloma therapy: targeting signal transduction pathways.Novel approaches to targeting MYD88 in Waldenström macroglobulinemia.Novel phosphatidylinositol 3-kinase inhibitor BKM120 enhances the sensitivity of multiple myeloma to bortezomib and overcomes resistance.Soluble and Cell-Cell-Mediated Drivers of Proteasome Inhibitor Resistance in Multiple Myeloma.
P2860

Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib.

Item
http://www.wikidata.org/entity/Q38971845
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Targeting survival and cell tr ...... I PI3K inhibitor, buparlisib.
@en
type
label
Targeting survival and cell tr ...... I PI3K inhibitor, buparlisib.
@en
prefLabel
Targeting survival and cell tr ...... I PI3K inhibitor, buparlisib.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Targeting survival and cell tr ...... I PI3K inhibitor, buparlisib.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698